Bank of America
PTHS

Bank of America’s Pelthos Therapeutics PTHS Stock Holding History

Bank of America’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$372 – 6977
2025
Q4 		$372 Buy
12
+1
+9% +$29 ﹤0.01% 6605
2025
Q3 		$308 Buy
11
+9
+450% +$218 ﹤0.01% 7665
2025
Q2 		$24 Buy
2
+1
+100% +$12 ﹤0.01% 8222
2025
Q1 		$17 Hold
1
– – ﹤0.01% 8160
2024
Q4 		$8 Hold
1
– – ﹤0.01% 8105
2024
Q3 		$8 Hold
1
– – ﹤0.01% 8065
2024
Q2 		$12 Buy
+1
New +$17 ﹤0.01% 8074

Other funds holding PTHS

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Bank of America's PTHS Position: Q1 2026 in Review

Bank of America sold out of Pelthos Therapeutics (PTHS) in Q1 2026, closing a stake of 12 shares — an estimated $372 sold.

Bank of America first reported a position in PTHS in Q2 2024 and held it in 7 quarters. The position peaked at $372 in Q4 2025. 17 funds tracked by Wall St. Rank hold PTHS as of Q1 2026.

  • Bank of America reported no remaining Pelthos Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 12 Pelthos Therapeutics shares in Q1 2026, an estimated $372.
  • Bank of America first reported a position in Pelthos Therapeutics in Q2 2024 and held it in 7 quarters.
  • Bank of America's Pelthos Therapeutics position peaked at $372 in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.